![]() AbCellera Biologics AbCellera Biologics is a provider of an AI-powered drug discovery platform for antibody therapies. | ![]() LakePharma LakePharma is a contract research organization (CRO) specializing in antibody and protein engineering, cell line development, and protein production. | ![]() Crescendo Biologics Crescendo Biologics is a provider of human VH antibody fragment therapeutics created to optimize antibodies and a transgenic mouse which produces heavy chain only antibodies. | ![]() Ablexis Ablexis is a company that commercializes a transgenic mouse platform AlivaMab for human therapeutic antibody discovery. | ![]() 10X Genomics 10X Genomics is a company building products for research institutions and pharmaceutical companies across the life sciences, including oncology, immunology, and neuroscience. | ![]() Bruker Cellular Analysis Bruker Cellular Analysis (formerly known as Phenomex, Berkeley Lights) is a digital cell biology company focused on enabling the development of biotherapeutics and other cell-based products. | |
Founding Date | Founding Date 2012 | Founding Date 2009 | Founding Date 2007 | Founding Date 2009 | Founding Date 2012 | Founding Date 2011 |
Type | Type Public | Type Private | Type Private | Type Private | Type Public | Type Subsidiary |
Tags | ||||||
Locations | Locations Vancouver, CA HQ | Locations San Carlos, US HQ Belmont, US Hayward, US Hopkinton, US Irving, US Worcester, US | Locations Babraham, GB HQ | Locations San Diego, US HQ | Locations Pleasanton, US HQ Shanghai, CN Leiden, NL Singapore, SG San Francisco, US | Locations Emeryville, US HQ |
Employees | Employees 596 | Employees 766% decrease | Employees 12 | Employees 1 | Employees 1,17810% decrease | Employees 1391% decrease |
Valuation ($) | Valuation ($) 833.9 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.9 b | Valuation ($) N/A |
Financial | ||||||
Revenue (est.) | Revenue (est.) $75.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) £7.5m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) $642.8m (FY, 2025) | Revenue (est.) $78.6m (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $198.9m (FY, 2025) | Cost of goods $24.8m (FY, 2022) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit £7.5m (FY, 2018) | Gross profit N/A | Gross profit $443.9m (FY, 2025) | Gross profit $53.8m (FY, 2022) |
Net income | Net income ($146.4m) (FY, 2025) | Net income N/A | Net income (£1.8m) (FY, 2018) | Net income N/A | Net income ($43.5m) (FY, 2025) | Net income ($98m) (FY, 2022) |
Funding | ||||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 70m (about 8 years ago) | Latest funding round $ 12m (almost 16 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 115m | Total funding raised N/A | Total funding raised $ 116.2m | Total funding raised $ 12m | Total funding raised $ 195.5m | Total funding raised $ 124.7m |

LakePharma is a contract research organization (CRO) specializing in antibody and protein engineering, cell line development, and protein production.
View company
Crescendo Biologics is a provider of human VH antibody fragment therapeutics created to optimize antibodies and a transgenic mouse which produces heavy chain only antibodies.
View company
Ablexis is a company that commercializes a transgenic mouse platform AlivaMab for human therapeutic antibody discovery.
View company
10X Genomics is a company building products for research institutions and pharmaceutical companies across the life sciences, including oncology, immunology, and neuroscience.
View company